These very residues have been suggested as a possible risk factor for breast cancer. Nevertheless, studies have shown that concentrations in tissue are low, and that evidence has not been conclusive. The classification of an unproven risk should not lull one into a benign sense of security. Potts explores the ways in which knowledge about breast cancer that is constructed by dominant biomedical experts does not rely on lived experiences to construct its truths and can, as a result, contradict lived, emotional and embodied experiences of breast cancer. These questions become mobilized in the form of political activism.
Faulty science is unmasked by personal accounts, and facts dissipate into fictitious data.
One such case was heard on Wednesday, April 13, 1994. Hearings before the Subcommittee on Oversight and Investigations examined the falsification and fabrication of data in some of the nation s most important clinical trials on the treatment and prevention of breast cancer. This case demonstrated major problems in the handling of patient s records. Patient s records were falsified and fabricated for over 13 years in the National Surgical Adjuvant Breast and Bowel Project. The Chair specifically states, Scientific misconduct is a very real problem that requires an intensive and aggressive response by the scientific community itself and by the Federal Government.